Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma
about
Somatic mutations in solid tumors: a spectrum at the service of diagnostic armamentarium or an indecipherable puzzle? The morphological eyes looking for BRAF and somatic molecular detections on cyto-histological samplesUpdate on anaplastic thyroid carcinoma: morphological, molecular, and genetic features of the most aggressive thyroid cancer.Cadherin-6 promotes EMT and cancer metastasis by restraining autophagy.The Art and Science of Thyroid Surgery in the Age of Genomics: 100 years after Theodor Kocher.BRAF inhibitors: experience in thyroid cancer and general review of toxicity.Contemporary and potential future molecular diagnosis of melanoma.The role of molecular diagnostic testing in the management of thyroid nodules.A combination of immunohistochemistry and molecular approaches improves highly sensitive detection of BRAF mutations in papillary thyroid cancer.Targeted next generation sequencing identifies somatic mutations and gene fusions in papillary thyroid carcinoma.Papillary Thyroid Carcinoma Metastasis to the Lumbar Spine Masquerading as a Schmorl's Node.Morphological features that can predict BRAFV600E -mutated carcinoma in paediatric thyroid cytology.The usefulness of a novel fully automated PCR-based Idylla test for detection of the BRAF V600E mutation in thyroid tissue: comparison with PNA-clamping PCR, real-time PCR and pyrosequencing.BRAF 1799T>A Mutation Frequency in Mexican Mestizo Patients with Papillary Thyroid Cancer.The bHLH transcription factor DEC1 promotes thyroid cancer aggressiveness by the interplay with NOTCH1
P2860
Q28070226-08041AE0-141D-47A8-8102-4D93142C5D64Q34152070-5E1E4870-0A9C-4ECB-B48E-87C93A568A54Q36067156-ECC3AC36-894B-4D82-BB9F-0CADEFA41EABQ37616588-6C2DB211-E7AE-4CF6-94F6-B28B4F5E7F94Q38281838-77DE578D-707A-4185-822B-E1D8971C64A9Q38847989-8BFDC89C-3F20-478B-A6CE-6CB56430029AQ39250953-0A787B54-F496-480C-8401-182D967FB5A2Q40619094-A2AEA830-CDA4-4E94-928A-D62982CB213CQ41233717-0A9C8FD0-3936-4035-ACFA-CE743CB1E1EBQ42433641-2FDF0F77-8CAB-4CB1-9B33-41E4C65E790EQ50891662-568A6B31-5331-407B-9F63-FCF132E1FED1Q51560869-ED836F5D-23D5-4E7D-B969-233D3A6D9E63Q54964968-83FC4550-136A-43C0-BD42-8269ED732B3DQ58695682-C243B48A-7AEA-4787-B9F6-CAE770344E7C
P2860
Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma
description
2015 nî lūn-bûn
@nan
2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma
@ast
Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma
@en
Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma
@nl
type
label
Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma
@ast
Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma
@en
Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma
@nl
prefLabel
Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma
@ast
Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma
@en
Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma
@nl
P2860
P50
P356
P1476
Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma
@en
P2093
Simonetta Piana
P2860
P304
P356
10.1002/IJC.28976
P407
P577
2015-09-01T00:00:00Z